Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Roesch

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Cancer Research|August 5, 2016
JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral CancersNicole D Facompre, Kayla M Harmeyer, Xavier Sole, et al.
Frontiers in Immunology|January 1, 2026
Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patientsCarl Maximilian Thielmann, Johanna Andrea Seier, Lisa Schielke, et al.
Cancers|February 9, 2020
Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of CancerMartin Metzenmacher, Renáta Váraljai, Balazs Hegedüs, et al.
Iscience|January 4, 2024
KDM5B predicts temozolomide-resistant subclones in glioblastomaVivien Ullrich, Sarah Ertmer, Anna Baginska, et al.
Cancer Cell|June 15, 2013
Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cellsAlexander Roesch, Adina Vultur, Ivan Bogeski, et al.
Cancer Research|November 23, 2021
BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor MicroenvironmentWei Liu, Paweł Stachura, Haifeng C Xu, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockadeEleftheria Chorti, Bernd Kowall, Jessica C Hassel, et al.
The British Journal of Dermatology|December 31, 2024
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanomaJan-Malte Placke, Jenny Bottek, Renata Váraljai, et al.
Frontiers in Immunology|March 3, 2025
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation statusJan-Malte Placke, Luisa Sophie Rajcsanyi, Rudolf Herbst, et al.
Cancer Medicine|October 18, 2013
Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastasesHeike Niessner, Andrea Forschner, Bernhard Klumpp, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Cancer Research|August 5, 2016
JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral CancersNicole D Facompre, Kayla M Harmeyer, Xavier Sole, et al.
Frontiers in Immunology|January 1, 2026
Extracorporeal photopheresis as a therapeutic approach for treatment resistant immune-related adverse events in anti-PD-1-treated melanoma patientsCarl Maximilian Thielmann, Johanna Andrea Seier, Lisa Schielke, et al.
Cancers|February 9, 2020
Plasma Next Generation Sequencing and Droplet Digital-qPCR-Based Quantification of Circulating Cell-Free RNA for Noninvasive Early Detection of CancerMartin Metzenmacher, Renáta Váraljai, Balazs Hegedüs, et al.
Iscience|January 4, 2024
KDM5B predicts temozolomide-resistant subclones in glioblastomaVivien Ullrich, Sarah Ertmer, Anna Baginska, et al.
Cancer Cell|June 15, 2013
Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cellsAlexander Roesch, Adina Vultur, Ivan Bogeski, et al.
Cancer Research|November 23, 2021
BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor MicroenvironmentWei Liu, Paweł Stachura, Haifeng C Xu, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockadeEleftheria Chorti, Bernd Kowall, Jessica C Hassel, et al.
The British Journal of Dermatology|December 31, 2024
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanomaJan-Malte Placke, Jenny Bottek, Renata Váraljai, et al.
Frontiers in Immunology|March 3, 2025
Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation statusJan-Malte Placke, Luisa Sophie Rajcsanyi, Rudolf Herbst, et al.
Cancer Medicine|October 18, 2013
Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastasesHeike Niessner, Andrea Forschner, Bernhard Klumpp, et al.
Pageof 11